Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-043942)

Filing Details

Accession Number:: 0000950170-25-043942
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-24 17:00:18
Reporting Period:: 2025-03-24

Filing Date:: 2025-03-24
Accepted Time:: 2025-03-24 17:00:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840904	Atai Life Sciences N.v.	ATAI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1845711	Ltd. Group Investment Apeiron	66 &Amp; 67 Beatrice, Amery Street Silema O1 SLM1707		No	No	No	No
1845872	Christian Angermayer	66 &Amp; 67 Amery Street Silema O1 SLM 1707		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2025-03-24	1,800,000	$1.40	42,369,415	No	4	P	Indirect	By Apeiron Investment Group Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Apeiron Investment Group Ltd.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	1,799,302	Indirect	By Apeiron Presight Capital Fund II, L.P.